Key Drivers
- Margin Expansion
- Weak Liquidity
- Cash Strength
AIAI Summary
HSTM is shifting from a sleepy defensive healthcare-software name to a cash-generative rerating story, as Q1 revenue grew 10.5% while operating income surged 71.6%, but the stock now hinges on sustaining margin expansion because its ~34x earnings valuation, weak liquidity, and intangible-heavy balance sheet leave little room for execution misses.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Weak Liquidity
- •Cash Strength
HSTM shows improving profitability and strong cash conversion, but weak liquidity and a rich valuation make it more of a hold than a clear bargain.
Price Behavior
Key Price Behavior Insights:
- •Breakout hold
- •Higher lows
- •Extended rally
HSTM has rallied strongly over the last month, breaking to a fresh high above $28 while holding $27.10-$27.30 as key support, but the move looks stretched and vulnerable to a short-term pullback if that breakout level fails.
Rapid run-up since 2026-06-25 suggests short-term extension and pullback risk
Sentiment & News
Key News Insights:
- •Relative-value focus
- •No operational update
- •Neutral stock selection
HealthStream was highlighted in a valuation-based comparison with Sify Technologies, signaling investor focus on relative value rather than any new operational development.
The coverage is likely neutral for HSTM, keeping attention on valuation appeal rather than creating a direct catalyst
Similar Companies in Healthcare
Other companies in the same sector with AI ratings